Proceedings of the National Academy of Sciences, Volume 123, Issue 24, June 2026. SignificancePan-sarbecovirus broadly neutralizing antibodies (bNAbs) are urgently needed to combat SARS-CoV-2 variants, mitigate future zoonotic spillover, and inform vaccine design. Here, we describe the isolation of bNAb lineages from a participant with …

Read original article